Schedule 13G ownership disclosure

Tenax Therapeutics, Inc.

Common Stock · CUSIP: 88032L605

Event date: 2025-11-28

Filing-level shares
623,733
Percent of class
9.99%
  • JANUS HENDERSON GROUP PLC

    Shares: 623,733 · Class: 9.99%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001274173-25-000344
Form type
SCHEDULE 13G
Filer
Janus Henderson Group Ltd.
CIK
CIK 1274173
Filed
Dec 08, 2025
Reporting period
Nov 28, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub